Arialys Therapeutics

Recent Finacing

Seed

Recent Raise

$58M

Arialys Therapeutics is a biotechnology company that develops precision medicines to target pathogenic autoantibodies in the central nervous system, with a focus on treating neuropsychiatric diseases caused by autoimmunity.